Michael Busch, MD

Dr. Busch is Director of Blood Systems Research Institute (BSRI) and Vice-President for Research and Scientific Affairs of Blood Systems, Inc. (BSI), a national network of over 30 blood centers throughout the United States. He is an Adjunct Professor of Laboratory Medicine at the University of California, San Francisco. Dr. Busch directs several national multi-center research studies, and his laboratory has an international reputation in the fields of viral safety and transfusion medicine, hosting visiting scholars from around the world. He has guided work in optimization and implementation of new nucleic amplification technology (NAT) for mass screening of blood donations for HIV, HCV, HBV and WNV. In addition, his laboratory holds several contracts for sample repositories and cell line development, for local studies and international projects. He has published over 200 original scientific articles and over 50 review articles and book chapters.

Steven Kleinman, MD

Dr. Kleinman is an internationally recognized expert in the field of blood safety.

Since 1996, he has been president of a transfusion medicine consulting company (Kleinman Biomedical Research) located in Victoria, BC whose clients include numerous blood collection organizations, government, and industry in both the US and Canada. He is also Clinical Professor of Pathology at U. British Columbia. He has published over 100 peer reviewed scientific articles and 18 book chapters and has co-edited a textbook in Transfusion Medicine. He has chaired the American Association of Blood Banks (AABB) Committee on Transfusion Transmitted Disease, the AABB Interagency Task Force on Bacterial Contamination of Platelets and the Consensus Panel of the 2004 Canadian Consensus Conference on TRALI.